Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thomas Adam Abrams, M.D.

Concepts (224)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Thomas Abrams's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Thomas Abrams has written about over time.
Antibodies, Monoclonal, 12 publications between 2009 and 2023, average publication date November 2013. Antineoplastic Agents, 13 publications between 2006 and 2023, average publication date December 2013. Camptothecin, 3 publications between 2012 and 2017, average publication date August 2014. Organoplatinum Compounds, 7 publications between 2009 and 2019, average publication date January 2015. Carcinoma, Hepatocellular, 13 publications between 2009 and 2023, average publication date January 2016. Fluorouracil, 6 publications between 2011 and 2019, average publication date June 2016. Biliary Tract Neoplasms, 6 publications between 2009 and 2023, average publication date September 2016. Colorectal Neoplasms, 9 publications between 2011 and 2024, average publication date December 2016. Liver Neoplasms, 15 publications between 2009 and 2023, average publication date December 2016. Gallbladder Neoplasms, 3 publications between 2014 and 2023, average publication date July 2017. Antineoplastic Combined Chemotherapy Protocols, 21 publications between 2009 and 2024, average publication date January 2018. Adenocarcinoma, 7 publications between 2011 and 2024, average publication date July 2018. Stomach Neoplasms, 5 publications between 2011 and 2024, average publication date August 2018. Pancreatic Neoplasms, 11 publications between 2008 and 2024, average publication date October 2018. Bile Duct Neoplasms, 6 publications between 2014 and 2024, average publication date September 2020. Cholangiocarcinoma, 6 publications between 2014 and 2024, average publication date September 2020. Receptor, Fibroblast Growth Factor, Type 2, 3 publications between 2021 and 2024, average publication date December 2022.

To see the data from this visualization as text, click here.
Abrams's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (224)
Explore
_
Co-Authors (105)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.